Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Cantor Fitzgerald
Novartis
Farmers Insurance
Accenture
Moodys
Chubb
McKesson
Deloitte
US Department of Justice

Generated: October 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203324

« Back to Dashboard
NDA 203324 describes PHOTREXA VISCOUS IN DEXTRAN 20%, which is a drug marketed by Avedro Inc and is included in one NDA. It is available from one supplier. Additional details are available on the PHOTREXA VISCOUS IN DEXTRAN 20% profile page.

The generic ingredient in PHOTREXA VISCOUS IN DEXTRAN 20% is riboflavin 5'-phosphate sodium. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the riboflavin 5'-phosphate sodium profile page.

Summary for NDA: 203324

You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM') AND hsdb_drugname IS NOT NULL' at line 1
Tradename:
2
Applicant:
1
Ingredient:
1
Patents:0